ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,430.40
      0.14%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      84.605
      -0.21%
      Bitcoin
      65,134.03
      -0.01%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU
      6. Galapagos (GLPG)

      7. Galapagos (GLPG) News

      GLPG

      Galapagos (GLPG)

      Galapagos
      		Date:
      Sort by:
       Showing the most relevant articles for your search:EU:GLPG
      DateTimeSourceHeadlineSymbolCompany
      08/18/20208:20PMDow Jones NewsGilead's Filgotinib, a Collaboration With Galapagos, Gets Complete Response Letter for Application From FDAEU:GLPGGalapagos
      08/18/20207:25PMGlobeNewswire Inc.Galapagos announces that Gilead received a complete response letter for filgotinib for the treatment of moderately to severel...EU:GLPGGalapagos
      08/18/20207:25PMGlobeNewswire Inc.Galapagos announces that Gilead received a complete response letter for filgotinib for the treatment of moderately to severel...EU:GLPGGalapagos
      08/12/20204:01PMGlobeNewswire Inc.Scipher Medicine and Galapagos sign collaboration in inflammatory bowel diseaseEU:GLPGGalapagos
      08/12/20204:01PMGlobeNewswire Inc.Scipher Medicine and Galapagos sign collaboration in inflammatory bowel diseaseEU:GLPGGalapagos
      08/06/20204:01PMGlobeNewswire Inc.Galapagos reports solid H1 2020 progressEU:GLPGGalapagos
      08/06/20204:01PMGlobeNewswire Inc.Galapagos reports solid H1 2020 progressEU:GLPGGalapagos
      07/24/20209:14AMDow Jones NewsGilead, Galapagos Say Arthritis Drug Gets Recommendation to Start Marketing in EuropeEU:GLPGGalapagos
      07/24/20208:14AMGlobeNewswire Inc.GILEAD  AND  GALAPAGOS  ANNOUNCE  POSITIVE  EUROPEAN  CHMP  OPINION  FOR  JYSELECA®  (FILGOTINIB)  FOR  THE  TR...EU:GLPGGalapagos
      07/24/20208:14AMGlobeNewswire Inc.GILEAD  AND  GALAPAGOS  ANNOUNCE  POSITIVE  EUROPEAN  CHMP  OPINION  FOR  JYSELECA®  (FILGOTINIB)  FOR  THE  TR...EU:GLPGGalapagos
      06/05/20204:01PMGlobeNewswire Inc.NEW ANALYSES OF PHASE 2 EQUATOR CLINICAL PROGRAM SUPPORT DURABLE EFFICACY OF FILGOTINIB IN PSORIATIC ARTHRITIS...EU:GLPGGalapagos
      06/05/20204:01PMGlobeNewswire Inc.NEW ANALYSES OF PHASE 2 EQUATOR CLINICAL PROGRAM SUPPORT DURABLE EFFICACY OF FILGOTINIB IN PSORIATIC ARTHRITIS...EU:GLPGGalapagos
      06/04/20201:00AMGlobeNewswire Inc.FILGOTINIB DEMONSTRATES DURABLE EFFICACY AND CONSISTENT SAFETY PROFILE AT 52 WEEKS IN FINCH 1 AND 3 STUDIES ...EU:GLPGGalapagos
      06/04/20201:00AMGlobeNewswire Inc.FILGOTINIB DEMONSTRATES DURABLE EFFICACY AND CONSISTENT SAFETY PROFILE AT 52 WEEKS IN FINCH 1 AND 3 STUDIES ...EU:GLPGGalapagos
      05/28/20204:01PMGlobeNewswire Inc.Galapagos increases share capital through subscription right exercisesEU:GLPGGalapagos
      05/28/20204:01PMGlobeNewswire Inc.Galapagos increases share capital through subscription right exercisesEU:GLPGGalapagos
      05/20/20205:08PMDow Jones NewsGilead, Galapagos: Filgotinib 200mg Achieved Primary Endpoints in Phase 2b/3 TrialEU:GLPGGalapagos
      05/20/20204:01PMGlobeNewswire Inc.GILEAD AND GALAPAGOS ANNOUNCE POSITIVE TOPLINE RESULTS OF PHASE 2B/3 TRIAL OF FILGOTINIB IN MODERATELY TO SEV...EU:GLPGGalapagos
      05/20/20204:01PMGlobeNewswire Inc.GILEAD AND GALAPAGOS ANNOUNCE POSITIVE TOPLINE RESULTS OF PHASE 2B/3 TRIAL OF FILGOTINIB IN MODERATELY TO SEV...EU:GLPGGalapagos
      05/07/20204:03PMGlobeNewswire Inc.On track for clinical read-outs and commercial readiness in 2020EU:GLPGGalapagos
      05/07/20204:03PMGlobeNewswire Inc.On track for clinical read-outs and commercial readiness in 2020EU:GLPGGalapagos
      04/17/20204:01PMGlobeNewswire Inc.Galapagos creates new subscription right plansEU:GLPGGalapagos
      04/17/20204:01PMGlobeNewswire Inc.Galapagos creates new subscription right plansEU:GLPGGalapagos
      04/16/20207:04PMGlobeNewswire Inc.Important update to Galapagos’ invitation to its ordinary and extraordinary shareholders’ meetingsEU:GLPGGalapagos
      04/16/20207:04PMGlobeNewswire Inc.Important update to Galapagos’ invitation to its ordinary and extraordinary shareholders’ meetingsEU:GLPGGalapagos
      04/16/20201:30AMGlobeNewswire Inc.Galapagos and Ryvu announce research collaborationEU:GLPGGalapagos
      04/16/20201:30AMGlobeNewswire Inc.Galapagos and Ryvu announce research collaborationEU:GLPGGalapagos
      03/27/20204:01PMGlobeNewswire Inc.Publication of the annual report and invitation to the ordinary and extraordinary shareholders’ meetingsEU:GLPGGalapagos
      03/27/20204:01PMGlobeNewswire Inc.Publication of the annual report and invitation to the ordinary and extraordinary shareholders’ meetingsEU:GLPGGalapagos
      03/17/20204:01PMGlobeNewswire Inc.Galapagos increases share capital through warrant exercisesEU:GLPGGalapagos
       Showing the most relevant articles for your search:EU:GLPG